A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease

Figure 3

Testing motor activity and response time in the pole test. DA5-CH reduced the motor impairment better than liraglutide.  < 0.001 and  < 0.01 compared to the control group; ^# =  < 0.05 and ^## =  < 0.01 compared to the A53T saline-treated group. Control = wild-type saline-treated animals, A53T = A53T saline-treated mice, DA5 = A53T DA5-treated mice, and liraglutide = A53T lira-treated mice. N = 12 per group.